A paper out of the UK entitled "A Virtual Clinic for Diabetes Self-Management: A Study" was published in the current issue of the Journal of Medical Internet Research. The study, conducted by the Warwick Medical School, is not huge in … Continue reading
One of the considerable elements re-shaping the marketing of pharmaceuticals in the United States has been the outlooks and activities and probable future legislation under advisement by members of Congress. While the various actions at the federal level have dominated … Continue reading
March madness is almost over, but my own seems to continue. What's that about? And I don't think the groundhog was right this year, Spring seems to be here in full force, at least by the looks of all the … Continue reading
Something I've written about before is the swing of the pendulum from the 1990s to the 2000s in terms of public priorities for the FDA. What is the balancing act between risk and benefit when it comes to both … Continue reading
Well the long era of suspense is over given the choices by the Obama Administration for the FDA and for HHS – in fact, the appointment game is winding down across the board, and federal agencies are getting down to … Continue reading
